News & Updates
Showing Endocrinology articles
Showing
Older age, insulin use, stroke linked to diabetic peripheral neuropathy in T2DM
Diabetic peripheral neuropathy (DPN) is not uncommon among patients with type 2 diabetes mellitus (T2DM) in Singapore and is significantly associated with increased age, Indian ethnicity, insulin use, diabetic retinopathy, and stroke, according to a recent study.
Older age, insulin use, stroke linked to diabetic peripheral neuropathy in T2DM
09 Dec 2021
Receipt of gender-affirming care reduces depression, suicidality in transgender, non-binary youth
Receipt of gender-affirming care led to a reduced risk of depression and suicidality among transgender and non-binary (TNB) youth, according to a prospective study presented at the American Academy of Pediatrics 2021 National Conference & Exhibition (AAP 2021).
Receipt of gender-affirming care reduces depression, suicidality in transgender, non-binary youth
06 Dec 2021
Empagliflozin beneficial and well tolerated in acute heart failure
Empagliflozin provides a significant clinical benefit within 90 days and shows no safety concerns in patients hospitalized for acute heart failure (HF), according to results of the EMPULSE trial reported at the American Heart Association (AHA) Scientific Sessions 2021.
Empagliflozin beneficial and well tolerated in acute heart failure
06 Dec 2021
Overeating a marker of poor mental health, adverse outcomes among teens with diabetes
Overeating or binge eating symptoms are linked to lower quality of life, higher prevalence of depression and anxiety, and poor clinical outcomes among adolescents with type 1 diabetes, according to a study.
Overeating a marker of poor mental health, adverse outcomes among teens with diabetes
02 Dec 2021
Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor
The glucagon-like peptide-1 receptor agonist (GLP-1 RA) efpeglenatide affords cardiovascular and renal protection that is not explained by concurrent use of a sodium-glucose co-transporter-2 (SGLT2) inhibitor in patients with type 2 diabetes (T2D), according to an exploratory analysis of AMPLITUDE-O.
Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor
30 Nov 2021
Remnant cholesterol tied to CVD death in patients with T2D, CKD, diabetic nephropathy
Remnant cholesterol (C) appears predictive of mortality due to cardiovascular disease (CVD) among patients with type 2 diabetes (T2D), chronic kidney disease (CKD) stage 3 to 5, and incident diabetic nephropathy (DN), suggests a study.